Breakthrough DNA Analysis Technology to Hasten Problem Diagnosis
|
By LabMedica International staff writers Posted on 25 Aug 2014 |

Image: A technical breakthrough for DNA imaging has been achieved that should quicken diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various pre-natal conditions (Photo courtesy of McGill University and Génome Québec Innovation Center).
Researchers have achieved a technical breakthrough that should result in speedier diagnosis of diseases for which analysis of DNA from single-cells is critical, such as early stage cancers and various prenatal conditions.
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
The key discovery lies in a new tool developed by a team led by Sabrina Leslie and Walter Reisner, both professors of physics at McGill University (Montreal, QC, Canada), and their collaborator Dr. Rob Sladek of the McGill University & Génome Québec Innovation Center (MUGQ Innovation Center; Montreal, Quebec, Canada). The tool enables the loading of long strands of DNA into a tunable nanoscale imaging chamber in ways that maintain structural identity and conditions similar to their in vivo physiology. This breakthrough method – “Convex Lens-Induced Confinement” (CLIC) (also referred to as convex lens-induced nanoscale templating (CLINT)) – will permit a rapid imaging-based mapping of large genomes while simultaneously identifying specific gene sequences from single cells with single-molecule resolution, a process critical to diagnosing certain types of diseases.
Existing tools used for single-cell genomic analysis rely on side-loading DNA and under pressure into nanochannels in the imaging chamber, a practice that breaks the DNA molecules into small pieces, making it a challenge to later reconstruct the genome. The CLIC tool can be set on top of a standard inverted fluorescence microscope and its innovative aspect lies in the fact that it allows strands of DNA to be loaded into the imaging chamber – from above – and in a process that allows the strands of DNA to maintain their integrity.
“It’s like squeezing many soft spaghetti noodles into long narrow tubes without breaking them,” explains Prof. Leslie, “Once these long strands of DNA are gently squeezed down into nanochannels from a nanoscale bath above, they become effectively rigid which means that we can map positions along uniformly stretched strands of DNA, while holding them still. This means diagnostics can be performed quickly, one cell at a time, which is critical for diagnosing many prenatal conditions and the onset of cancer.”
“Current practices of genomic analysis typically require tens of thousands of cells worth of genomic material to obtain the information we need, but this new approach works with single cells,” said Dr. Sladek, “CLIC will allow researchers to avoid having to spend time stitching together maps of entire genomes as we do under current techniques, and promises to make genomic analysis a much simpler and more efficient process.”
“Nanoscale physics has so much to offer biomedicine and diagnostics,” added Prof. Leslie, “CLIC brings the nanoscale regime to the bench top, and genomics is just the beginning”.
The work was described by Berarda DJ et al. in the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS), August 4, 2014, online ahead of print.
Related Links:
McGill University
The McGill University and Génome Québec Innovation Center
Latest Technology News
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
- Taste-Based Influenza Test Could Replace Nasal Swabs with Chewing Gum
- 3D Micro-Printed Sensors to Advance On-Chip Biosensing for Early Disease Detection
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
New Molecular Test Improves Diagnostic Accuracy of Lyme Disease
Diagnosing Lyme disease early remains one of the biggest challenges in infectious disease care. The condition is increasing across the United States, especially in the Northeast, although many patients... Read more
New Genetic Test Enables Faster Diagnosis of Rare Diseases
Rare disease diagnosis often involves a long and uncertain search for the underlying genetic cause. Traditional testing requires multiple separate analyses, although many patients remain without answers.... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read more
Blood-Based Liquid Biopsy Model Analyzes Immunotherapy Effectiveness
Immunotherapy has revolutionized cancer care by harnessing the immune system to fight tumors, yet predicting who will benefit remains a major challenge. Many patients undergo costly and taxing treatment... Read moreMicrobiology
view channel
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
Extrapulmonary tuberculosis (EPTB) remains difficult to diagnose and treat because it spreads beyond the lungs and lacks easily accessible biomarkers. Despite TB infecting 10 million people yearly, the... Read more
15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
Distinguishing minor childhood illnesses from potentially life-threatening infections such as sepsis or meningitis remains a major challenge in emergency care. Traditional tests can take hours, leaving... Read more
High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
Gastrointestinal (GI) infections are among the most common causes of illness worldwide, leading to over 1.7 million deaths annually and placing a heavy burden on healthcare systems. Conventional diagnostic... Read morePathology
view channel
AI Tool Predicts Treatment Success in Rectal Cancer Patients
Artificial intelligence (AI) may soon help clinicians identify which rectal cancer patients are likely to respond well to treatment, using only the routine biopsy slides already obtained at diagnosis.... Read more
Blood Test and Sputum Analysis Predict Acute COPD Exacerbation
Chronic obstructive pulmonary disease (COPD) remains a major contributor to global illness, largely driven by cigarette smoking and marked by irreversible lung damage. Acute exacerbations can accelerate... Read more
AI Tool to Transform Skin Cancer Detection with Near-Perfect Accuracy
Melanoma continues to be one of the most difficult skin cancers to diagnose because it often resembles harmless moles or benign lesions. Traditional AI tools depend heavily on dermoscopic images alone,... Read more
Unique Immune Signatures Distinguish Rare Autoimmune Condition from Multiple Sclerosis
Myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) is a rare autoimmune disorder in which the immune system attacks the myelin sheath in the central nervous system. Although symptoms... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more








